Prediction of metastatic breast cancer in non-sentinel lymph nodes based on metalloprotease-1 expression by the sentinel lymph node

European Journal of Cancer

Volumn 49, Issue 5, 2013, Pages 1009-1017

  Eiró, Noemí ^a   González, Luis O ^a   Atienza, Sara ^a   González Quintana, José M ^a   Beridze, Nana ^a   Fernandez Garcia, Belen ^a   Pérez Fernández, Román ^b   García Caballero, Tomás ^c   Schneider, José ^d   Vizoso, Francisco J ^a  

^a HOSPITAL DE JOVE   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Breast cancer; Inflammatory cells; Matrix metalloprotease 1; Metalloproteases; Metastasis; Sentinel lymph node biopsy

Indexed keywords

INTERSTITIAL COLLAGENASE;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST METASTASIS; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; MORBIDITY; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; STROMA CELL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COHORT STUDIES; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASES; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 84874935178     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.09.019     Document Type: Article

References (42)

1. A.E. Giuliano, P.S. Dale, R.R. Turner, D.L. Morton, S.W. Evans, and D.L. Krasne Improved axillary staging of breast cancer with sentinel lymphadenectomy Ann Surg 222 3 1995 394 399 discussion 399-401
2. D.N. Krag, D.L. Weaver, J.C. Alex, and J.T. Fairbank Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe Surg Oncol 2 6 1993 335 339 discussion 340
3. A.E. Giuliano, K.K. Hunt, and K.V. Ballman Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial JAMA 305 6 2011 569 575
4. A. Domenech, A. Benitez, and M.T. Bajen What are the preoperative factors that can determine the presence of metastases in other axillary nodes in breast cancer when the sentinel node is positive? Q J Nucl Med Mol Imaging 53 4 2009 422 427
5. W.K. Hung, M.C. Chan, and K.L. Mak Non-sentinel lymph node metastases in breast cancer patients with metastatic sentinel nodes ANZ J Surg 75 1-2 2005 27 31
6. G. Cserni Sentinel lymph-node biopsy-based prediction of further breast cancer metastases in the axilla Eur J Surg Oncol 27 6 2001 532 538
7. F.J. Fleming, D. Kavanagh, and T.B. Crotty Factors affecting metastases to non-sentinel lymph nodes in breast cancer J Clin Pathol 57 1 2004 73 76
8. R.F. Hwang, S. Krishnamurthy, and K.K. Hunt Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer Ann Surg Oncol 10 3 2003 248 254
9. G. Viale, E. Maiorano, and G. Pruneri Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy Ann Surg 241 2 2005 319 325
10. N. Wada, S. Imoto, C. Yamauchi, T. Hasebe, and A. Ochiai Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node Eur J Surg Oncol 32 1 2006 29 33
11. A. Goyal, A. Douglas-Jones, R.G. Newcombe, and R.E. Mansel Predictors of non-sentinel lymph node metastasis in breast cancer patients Eur J Cancer 40 11 2004 1731 1737
12. S.L. Wong, M.J. Edwards, and C. Chao Predicting the status of the nonsentinel axillary nodes: a multicenter study Arch Surg 136 5 2001 563 568
13. B. Unal, A.S. Gur, and S. Beriwal Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study Int J Radiat Oncol Biol Phys 75 4 2009 1035 1040
14. S.F. Abdessalam, E.E. Zervos, and M. Prasad Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer Am J Surg 182 4 2001 316 320
15. A.C. Degnim, K.A. Griffith, and M.S. Sabel Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients Cancer 98 11 2003 2307 2315
16. R.R. Turner, K.U. Chu, and K. Qi Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node Cancer 89 3 2000 574 581
17. A.S. Gur, B. Unal, and R. Johnson Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy J Am Coll Surg 208 2 2009 229 235
18. A. Katz, B.L. Smith, and M. Golshan Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer J Clin Oncol 26 13 2008 2093 2098
19. E. Tousimis, K.J. Van Zee, and J.V. Fey The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers J Am Coll Surg 197 4 2003 529 535
20. K.J. Van Zee, D.M. Manasseh, and J.L. Bevilacqua A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy Ann Surg Oncol 10 10 2003 1140 1151
21. H.S. Cody 3rd, and K.J. Van Zee Predicting nonsentinel node metastases in sentinel node-positive breast cancer: what have we learned, can we do better, and do we need to? Ann Surg Oncol 15 11 2008 2998 3002
22. K.M. Erb, and T.B. Julian Completion of axillary dissection for a positive sentinel node: necessary or not? Curr Oncol Rep 11 1 2009 15 20
23. J.M. Del Casar, L.O. Gonzalez, and E. Alvarez Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas Breast Cancer Res Treat 116 1 2009 39 52
24. L.O. Gonzalez, M.D. Corte, and S. Junquera Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma Hum Pathol 40 9 2009 1224 1233
25. L.O. Gonzalez, S. Gonzalez-Reyes, and L. Marin Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumour stromal mononuclear inflammatory cells and those at the invasive front of breast carcinomas Histopathology 57 6 2010 862 876
26. L.O. Gonzalez, I. Pidal, and S. Junquera Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse Br J Cancer 97 7 2007 957 963
27. F.J. Vizoso, L.O. Gonzalez, and M.D. Corte Study of matrix metalloproteinases and their inhibitors in breast cancer Br J Cancer 96 6 2007 903 911
28. L.O. Gonzalez, M.D. Corte, and J. Vazquez Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast Histopathology 53 4 2008 403 415
29. G.H. Lyman, A.E. Giuliano, and M.R. Somerfield American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 30 2005 7703 7720
30. D.C. Allred, J.M. Harvey, M. Berardo, and G.M. Clark Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 11 2 1998 155 168
31. T.W. Jacobs, A.M. Gown, H. Yaziji, M.J. Barnes, and S.J. Schnitt Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system J Clin Oncol 17 7 1999 1983 1987
32. J.L. Fougo, M. Afonso, and F. Senhoraes Senra Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors? Clin Transl Oncol 11 3 2009 165 171
33. J.S. Scow, A.C. Degnim, T.L. Hoskin, C. Reynolds, and J.C. Boughey Simple prediction models for breast cancer patients with solitary positive sentinel nodes-are they valid? Breast J 15 6 2009 610 614
34. R. Ala-aho, and V.M. Kahari Collagenases in cancer Biochimie 87 3-4 2005 273 286
35. C.E. Brinckerhoff, J.L. Rutter, and U. Benbow Interstitial collagenases as markers of tumor progression Clin Cancer Res 6 12 2000 4823 4830
36. T.P. Padera, A. Kadambi, and E. di Tomaso Lymphatic metastasis in the absence of functional intratumor lymphatics Science 296 5574 2002 1883 1886
37. S.Y. Wong, and R.O. Hynes Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle 5 8 2006 812 817
38. S.A. Brooks, and A.J. Leathem Prediction of lymph node involvement in breast cancer by detection of altered glycosylation in the primary tumour Lancet 338 8759 1991 71 74
39. J. Schneider, M. Pollan, and A. Ruibal Histologic grade and CD44 are independent predictors of axillary lymph node invasion in early (T1) breast cancer Tumour Biol 20 6 1999 319 330
40. A. Smeets, A. Daemen, and I. Vanden Bempt Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs Breast Cancer Res Treat 129 3 2011 767 776
41. Y. Wang, J.G. Klijn, and Y. Zhang Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 365 9460 2005 671 679
42. M.F. Garcia, S. Gonzalez-Reyes, and L.O. Gonzalez Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer Int J Exp Pathol 91 4 2010 324 334